Akebia Therapeutics, Inc.AKBANASDAQ
Loading
Interest Expense Over TimeExpanding
Percentile Rank100
3Y CAGR+15.5%
5Y CAGR+22.2%
Year-over-Year Change
Interest expense on outstanding debt
3Y CAGR
+15.5%/yr
Annual compound
5Y CAGR
+22.2%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
2.7x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $24.18M | +33.0% |
| 2024 | $18.18M | +201.5% |
| 2023 | $6.03M | -61.5% |
| 2022 | $15.69M | -21.3% |
| 2021 | $19.94M | +124.7% |
| 2020 | $8.87M | +533.6% |
| 2019 | $1.40M | - |
| 2018 | $0.00 | - |
| 2017 | $0.00 | - |
| 2016 | $0.00 | - |